Advancements in tissue engineering for cardiovascular health: a biomedical engineering perspective
Frontiers in Bioengineering and Biotechnology · 31.05.2024 · 12
DOI: 10.3389/fbioe.2024.1385124 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Bioengineering and Biotechnology, online erschienen am 31.05.2024. Verfasst von Zahra-Sadat Razavi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Physiology Research Center, Iran University of Medical Sciences, Tehran, Iran. Die Arbeit wurde bisher 64-mal zitiert (Crossref) und nennt 144 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Myocardial infarction (MI) stands as a prominent contributor to global cardiovascular disease (CVD) mortality rates. Acute MI (AMI) can result in the loss of a large number of cardiomyocytes (CMs), which the adult heart struggles to replenish due to its limited regenerative capacity. Consequently, this deficit in CMs often precipitates severe complications such as heart failure (HF), with whole heart transplantation remaining the sole definitive treatment option, albeit constrained by inherent limitations. In response to these challenges, the integration of bio-functional materials within cardiac tissue engineering has emerged as a groundbreaking approach with significant potential for cardiac tissue replacement. Bioengineering strategies entail fortifying or substituting biological tissues through the orchestrated interplay of cells, engineering methodologies, and innovative materials. Biomaterial scaffolds, crucial in this paradigm, provide the essential microenvironment conducive to the assembly of functional cardiac tissue by encapsulating contracting cells. Indeed, the field of cardiac tissue engineering has witnessed remarkable strides, largely owing to the application of biomaterial scaffolds. However, inherent complexities persist, necessitating further exploration and innovation. This review delves into the pivotal role of biomaterial scaffolds in cardiac tissue engineering, shedding light on their utilization, challenges encountered, and promising avenues for future advancement. By critically examining the current landscape, we aim to catalyze progress toward more effective solutions for cardiac tissue regeneration and ultimately, improved outcomes for patients grappling with cardiovascular ailments.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Physiology Research Center, Iran University of Medical Sciences, Tehran, Iran.
- Department of Mechanical Engineering, K. N. Toosi University of Technology, Tehran, Iran.
- Department of Electrical and Computer Engineering, University of Waterloo, Waterloo, ON, Canada.
- Centre for Sustainable Business, International Business University, Toronto, ON, Canada.
- Student Research Committee, USERN Office, Lorestan University of Medical Sciences, Khorramabad, Iran.
- Department of Chemistry, Iran University of Science and Technology, Tehran, Iran.
Zitieren
APA
Razavi, Z. S., Soltani, M., Mahmoudvand, G., Farokhi, S., Karimi-Rouzbahani, A., Farasati-Far, B., Tahmasebi-Ghorabi, S., Pazoki-Toroudi, H., & Afkhami, H. (2024). Advancements in tissue engineering for cardiovascular health: a biomedical engineering perspective. Frontiers in Bioengineering and Biotechnology, 12. https://doi.org/10.3389/fbioe.2024.1385124
Vancouver
Razavi ZS, Soltani M, Mahmoudvand G, Farokhi S, Karimi-Rouzbahani A, Farasati-Far B, et al. Advancements in tissue engineering for cardiovascular health: a biomedical engineering perspective. Frontiers in Bioengineering and Biotechnology. 2024;12. doi:10.3389/fbioe.2024.1385124
BibTeX
@article{Razavi2024,
author = {Razavi, Zahra-Sadat and Soltani, Madjid and Mahmoudvand, Golnaz and Farokhi, Simin and Karimi-Rouzbahani, Arian and Farasati-Far, Bahareh and Tahmasebi-Ghorabi, Samaneh and Pazoki-Toroudi, Hamidreza and Afkhami, Hamed},
title = {Advancements in tissue engineering for cardiovascular health: a biomedical engineering perspective},
journal = {Frontiers in Bioengineering and Biotechnology},
year = {2024},
volume = {12},
doi = {10.3389/fbioe.2024.1385124}
}
EUVIMED